Icon

CEFZIL (nda050664)- (250MG,500MG)

CEFPROZIL CORDEN PHARMA
250MG,500MG
No No
Expired Expired
None None
None No
CEFZIL is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below: UPPER RESPIRATORY TRACT - Pharyngitis/tonsillitis caused by Streptococcus pyogenes, Otitis Media caused by Streptococcus pneumoniae, Acute Sinusitis caused by Streptococcus pneumoniae. LOWER RESPIRATORY TRACT - Acute Bacterial Exacerbation of Chronic Bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae. SKIN AND SKIN STRUCTURE - Uncomplicated Skin and Skin-Structure Infections caused by Staphylococcus aureus and Streptococcus pyogenes.
7 0 3
Total Other Developers None
Drugs with Suitability No
250MG ** ** - 3 -
500MG ** ** - - 3
NDA Sales Available Total Generic Sales Available
No 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ***** ******* *** *********** ****-*, ***-***, *** ********** **** **. *, ****. ******, *********, ****** ******* ******, ***** (***) ***
****** ***** ***** ******* *********** ****-*, ***-***, *** ********** **** **. *, ****. ******, *********, ****** ******* ******, ***** (***) ***
****** ********* ****** ********* ****** ******* *********** ****-**, **. **.***/** & ***/**, ******* *******, ********** ******, ***** ***** ********, **********, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.